Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy

Professor Sir John Burn; Professor John Mathers; Dr Anne-Marie Gerdes

Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy Lookup NU author(s) Professor Sir John Burn Professor John Mathers Dr Anne-Marie Gerdes



Author(s)		Burn J, Mathers JC, Gerdes AM, Bisgaard ML, Evans G, Eccles D, Lindblom A, Macrae F, Maher ER, Mecklin JP, Moslein G, Olschwang S, Ramesar R, Vasen HFA, Wijnen J, Barker G, Elliott F, Lynch H, Bishop DT, CAPP2 Consortium
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		Annals of Oncology: European Multidisciplinary Colorectal Cancer Congress
Conference Location		Nice, France
Year of Conference		2010
Date		28-30 March 2010
Volume		21, s1
Pages		I16

ISBN		15698041




Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		Oxford University Press
Actions
Library holdings		Search Newcastle University Library for this item